Price: 86.13

Today's Change: 0.14

Today's Percent Change: 0.39%

Today's Volume: 846361

Average Daily Volume: 1572760

52 week low: 66.93

52 week high: 86.9

Market cap: 201790000000.0

EBITDA: 14460000000.0

EBITDA / market_cap: 7.17%

Earnings per Share (EPS): 2.74

EPS / price: 3.18%

Dividend Yield: 3.16%

Dividend per share: 2.72

Book value: 29.84

Price to Book Ratio: 2.88

Price to Earnings (P/E) Ratio: 31.45

Price to Earnings Growth (PEG) Ratio: 3.23

Price to Sales (P/S) Ratio: 4.1

Short Ratio: 1.69

Exchange: "NYQ"

Short term: UP (Previous: UP)

Mid term: UP (Previous: UP)

Long term: UP (Previous: UP)

Support: 72.70

Resistance: 73.18

Pivot point: 72.95

SMA 10: 73.69

SMA 50: 74.24

SMA 100: 71.49

RSI 10: 33.64

RSI 50: 49.86

RSI 100: 50.15

EMA 10: 73.80

EMA 50: 74.13

EMA 100: 70.67

STRONG BUY

Based on 12 buy signals and 0 sell signals

Previous signal: strong buy

73.91

NEGATIVE

NVS
NVS

@BioCentury: RT @BioPharmaJosh: Abbisko is a China biotech to watch. CEO helped set up $NVS NIBR in China, backed by top-tier China investors (Qiming, L…

@NewsToDesk: $BIIB $NVS: Analysts Digest Biogen’s Alzheimer’s Disappointment: ‘There Isn’t …: https://t.co/4dwcllmn9j

@bulletin_en: As Novartis Ag $NVS Shares Declined, Dodge & Cox Decreased Its Stake https://t.co/3MRd27eaRI

@Escells: Synthetic Biologics, Inc. $SYN Pioneering Cutting-edge Research into Clinical Science Designed to Protect and Prese… https://t.co/8SdJTD7Cij

@bulletin_en: On April, 18 Analysts See $1.24 EPS for Novartis AG $NVS https://t.co/BL3xWxMLwQ

@IBD_AGatlin: Biogen is a "wounded cash cow," but it keeps investing in #Alzheimer's $BIIB $PFE $RHHBY $LLY $NVS https://t.co/zGTWpUTRKC

@mmahotstuff1: Trust Co Of Oklahoma Has Trimmed Its Stake in Novartis Ag Sponsored Adr $NVS by $21.45 Million as Stock Value Decli… https://t.co/YDlSMlf69P

@MomentumBeast: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj … $IBB $GILD $NVS… https://t.co/XuA5wPZiLt

@MomentumBeast: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/UUij8rIiH6

@MomentumBeast: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/ClvplourrI

@statnews: RT @pharmalot: Up and Down the Ladder: Job Changes.. the latest comings and goings.. recognize anyone? https://t.co/0F52xtRHFr #pharma #job…

@ZolmaxNews: Novartis AG $NVS Receives Consensus Rating of “Hold” from Brokerages https://t.co/TFd2Bt7L7C

@dailypoliticaln: Novartis AG $NVS Receives Average Rating of “Hold” from Brokerages https://t.co/0drkuxh98V

@AmericanBanking: Novartis AG $NVS Receives Average Rating of “Hold” from Brokerages https://t.co/9XOF35cyqs #stocks